Inactivation of Material from SARS-CoV-2-Infected Primary Airway Epithelial Cell Cultures.

Barrow, Kaitlyn A; Rich, Lucille M; Vanderwall, Elizabeth R; Reeves, Stephen R; Rathe, Jennifer A; White, Maria P; Debley, Jason S

Barrow, Kaitlyn A; Rich, Lucille M; Vanderwall, Elizabeth R; Reeves, Stephen R; Rathe, Jennifer A; White, Maria P; Debley, Jason S.

Afiliação

Barrow KA; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Rich LM; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Vanderwall ER; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Reeves SR; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Rathe JA; Department of Pediatrics, Division of Pulmonary and Sleep Medicine, Seattle Children's Hospital, University of Washington, Seattle, WA 98101, USA.
White MP; Department of Pediatrics, Division of Infectious Disease, Seattle Children's Hospital, University of Washington, Seattle, WA 98101, USA.
Debley JS; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Methods Protoc ; 4(1)2021 Jan 07.

Article em En | MEDLINE | ID: mdl-33430421

Palavras-chave

COVID-19; RNA; SARS-CoV-2; Vero E6; airway; epithelial; heat; inactivation; protein

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Methods Protoc Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google